Search - tctmd.com

Displaying 561 - 580 of 4093

Sort: Relevancy | Date

Presentation THT 2024

Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy

Presenter: Paul Forfia

March 06, 2024

Presentation THT 2024

Reclassification of PH Based with New Endo-Phenotypes

Presenter: Evelyn Miriam Horn

March 06, 2024

Presentation THT 2024

Post PE Syndrome

Presenter: Paul Forfia

March 06, 2024

Presentation THT 2024

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Presenter: Candice Lee

March 06, 2024

Presentation THT 2024

Case Resolution

Presenter: Sareena George

March 06, 2024

Presentation THT 2024

Catheters Are Over-Rated! Heparin as the Primary Option

Presenter: Sanjum S. Sethi

March 06, 2024

Presentation THT 2024

Catheter Directed Lytics as the Primary Option

Presenter: Adnan Khalif

March 06, 2024

Presentation THT 2024

Catheter Thrombectomy as the Primary Option

Presenter: Kenneth Rosenfield

March 06, 2024

Presentation THT 2024

Case Presentation

Presenter: Sareena George

March 06, 2024

Presentation THT 2024

Risk Stratification and Treatment Goals of Acute PE

Presenter: Catalin Toma

March 06, 2024

Presentation THT 2024

Remote PA Pressure Monitoring: Where are we now and where are we going?

Presenter: Akshay Desai

March 05, 2024

Presentation THT 2024

Cordella System Overview

Presenter: Yasmin Raza

March 05, 2024

Presentation THT 2024

Endovascular Carotid Sinus Mechanical Stimulation

Presenter: Horst Sievert

March 05, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Presenter: Sanjiv J. Shah

March 05, 2024

Presentation THT 2024

Beyond Supine Pulmonary Artery Pressures

Presenter: Marat Fudim

March 05, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon Litwin

March 04, 2024

Presentation THT Abstracts 2024

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Presenter: Robert Zilinyi

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Presenter: Marat Fudim

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon E. Litwin

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Presenter: Marat Fudim

March 04, 2024

Advertisement

Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy

Reclassification of PH Based with New Endo-Phenotypes

Post PE Syndrome

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Case Resolution

Catheters Are Over-Rated! Heparin as the Primary Option

Catheter Directed Lytics as the Primary Option

Catheter Thrombectomy as the Primary Option

Case Presentation

Risk Stratification and Treatment Goals of Acute PE

Remote PA Pressure Monitoring: Where are we now and where are we going?

Cordella System Overview

Endovascular Carotid Sinus Mechanical Stimulation

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Beyond Supine Pulmonary Artery Pressures

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content